午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >N-cyclohexyl-N-phenylnitrous amide
N-cyclohexyl-N-phenylnitrous amide
  • N-cyclohexyl-N-phenylnitrous amide
  • N-cyclohexyl-N-phenylnitrous amide
  • N-cyclohexyl-N-phenylnitrous amide
  • N-cyclohexyl-N-phenylnitrous amide
  • N-cyclohexyl-N-phenylnitrous amide

N-cyclohexyl-N-phenylnitrous amide NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-06-18

Product Details

Product Name: N-cyclohexyl-N-phenylnitrous amide CAS No.: 54955-24-7
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/06/18

N-cyclohexyl-N-phenylnitrous amide;54955-24-7

Article illustration

Product Information

  • Product Code:N031286

  • English Name:N-cyclohexyl-N-phenylnitrous amide

  • English Alias:N-cyclohexyl-N-phenylnitrous amide

  • CAS No.:54955-24-7

  • Molecular Formula:C??H??N?O

  • Molecular Weight:204.27

Advantages

  • High-Purity Reference Standard:Confirmed by HPLC (≥99.0%), NMR (1H, 13C), and HRMS, suitable for precise analysis of nitrosamine impurities.

  • Stability Assurance:Stable for 24 months at -20℃ under light-protected, sealed storage; degradation rate <0.5% in acetonitrile solution within 3 months.

Applications

  • Drug Safety Testing:Used for LC-MS/MS detection of nitrosamine impurities in related drugs, complying with ICH M7 guidelines for genotoxic impurity control (≤0.1 ppm).

  • Process Risk Assessment:Monitors N-cyclohexyl-N-phenylnitrous amide generated from nitrosation side reactions during drug synthesis, reducing impurity levels by optimizing reaction conditions (e.g., avoiding sodium nitrite excess, controlling acidic pH).

  • Method Validation:Serves as a standard for developing nitrosamine detection methods, verifying sensitivity (LOD down to 0.01 ng/mL) and specificity.

Background Description

N-nitroso compounds (such as N-cyclohexyl-N-phenylnitrous amide) are prioritized for control by regulatory agencies (FDA, EMA) due to potential genotoxicity and carcinogenicity. These impurities can form during synthesis via reactions between secondary amines and nitrosating agents or accumulate under storage conditions. With the implementation of ICH M7, detection and control of such impurities have become critical for drug quality.

Research Status

  • Detection Technology:UPLC-MS/MS with C18 column (1.7μm) and 0.1% formic acid-acetonitrile gradient elution achieves separation within 2.5 minutes, with LOD of 0.005 ng/mL for trace analysis.

  • Formation Mechanism:Originates from the reaction of cyclohexylamine and aniline derivatives with nitrite under acidic conditions (pH <3). Adding nitrosamine inhibitors (e.g., ascorbic acid) or optimizing purification (e.g., SPE) reduces content by >80%.

  • Safety Evaluation:Preliminary toxicology shows positive Ames test results, indicating potential mutagenicity. Current standards limit it to ≤0.1 ppm, requiring continuous monitoring via accelerated and long-term stability studies.

  • We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
    This product is intended for laboratory use only!

    WhatsAPP: +86 17320513646
    E-mail: anna@molcoo.com


    NEW IN STOCK!

    The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 

Company Profile Introduction

1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability. 2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs. 3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects. 4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes. 5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1kg
VIP1Y
Wuhan Circle Star Chem-medical Technology Co.,Ltd
2025-01-16
$39.00/2mg
VIP5Y
TargetMol Chemicals Inc.
2025-07-12
$6.00/1kg
VIP1Y
HebeiShuoshengImportandExportco.,Ltd
2024-08-07
INQUIRY